Upstream Bio (UPB) Receivables - Net (2023 - 2026)

Upstream Bio's Receivables - Net history runs 4 years deep, the most recent figure standing at $1.0 million for Q1 2026.

• In Q1 2026, Receivables - Net rose 82.69% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (up 82.69% YoY), while the FY2025 annual figure was $668000.0, up 8.97% from the prior year.
• Receivables - Net for Q1 2026 stood at $1.0 million, up from $668000.0 in the prior quarter.
• The five-year high for Receivables - Net was $1.0 million in Q1 2026, with the low at $98000.0 in Q4 2023.
• The 4-year median for Receivables - Net is $613000.0 (2024), against an average of $611777.8.
• The sharpest annual moves came in 2024 and 2025: Receivables - Net soared 525.51% in 2024, then climbed 8.97% in 2025.
• Upstream Bio's Receivables - Net stood at $98000.0 in 2023, then jumped by 525.51% to $613000.0 in 2024, then climbed by 8.97% to $668000.0 in 2025, then soared by 54.79% to $1.0 million in 2026.
• Business Quant data shows UPB's Receivables - Net at $1.0 million in Q1 2026, $668000.0 in Q4 2025, and $683000.0 in Q3 2025.